actin related protein 2/3 complex subunit 3 pseudogene 3Genealiases: []
Q-omics provides the consensus-scored ARPC3P3 profile across patient tissues and cancer cell-line models. ARPC3P3 expression is associated with patient survival in 26 of 34 cancer types, with the highest sampling consensus in UVM. Among the 18 cancer types available for tumor–normal comparison, ARPC3P3 is differentially expressed in 14, with the highest sampling consensus in LIHC. Additionally, ARPC3P3 RNA expression shows 14,717 significant gene co-expression associations, with the highest sampling consensus in UVM. Together, these results highlight UVM, and LIHC as cancer lineages where ARPC3P3 shows reproducible signals across survival, tumor–normal expression, and patient cross-omics analyses.
Every result is evaluated using two consensus scores. Sampling consensus measures how consistently a finding is reproduced within a cancer lineage across different conditions. Lineage consensus measures how broadly the result is shared across cancer types, distinguishing pan-cancer signals from lineage-specific patterns.
Premium analyses for ARPC3P3 — synthetic lethality, tumor antigen, and pembrolizumab response.
This table summarizes ARPC3P3 survival associations across molecular data types. ARPC3P3 RNA expression shows survival associations in the most cancer types (26). The rightmost column indicates the cancer type with the highest sampling consensus for each molecular layer.
This table ranks reproducible ARPC3P3 RNA expression–survival associations across cancer types. High ARPC3P3 expression shows unfavorable associations in UVM, MESO, LIHC, KICH and LUAD, but favorable associations in CESC. The UVM Kaplan–Meier curve shows clear separation, with the high-expression group declining faster, consistent with the unfavorable association (log-rank p < 0.001). Together, the overview and detailed table identify UVM as the clearest survival context for ARPC3P3 RNA expression.
This table summarizes ARPC3P3 tumor–normal expression differences by data type. RNA shows broader differences across cancer types, with a lineage consensus of 14. The strongest signals are observed in LIHC for RNA.
This table ranks reproducible tumor–normal expression differences for ARPC3P3. A negative fold-change indicates higher expression in normal tissue than in tumor tissue. ARPC3P3 shows higher tumor expression in LIHC, HNSC, KIRP, BRCA, KIRC and COAD. The LIHC box plot shows higher ARPC3P3 RNA expression in tumor versus normal tissue (log2 FC = +0.633, t-test p < 0.001).
This table shows molecular features associated with ARPC3P3 in patient tissues and cancer cell lines. In patient samples, ARPC3P3 shows the broadest associations at the RNA and protein expression levels, with UVM recurring as the lineage with the largest associated feature set.
